Crospon raises €3m in funding
The company, set up in June 2006, said the funding will be used to help develop its treatments for diabetes and gastroesophageal reflux disorder.
Crospon said the funding follows an initial €2.3m last year, came from the Western Development Commission and a number of private investors.